PHS
SGEN

PFM Health Sciences’s Seagen Inc. Common Stock SGEN Stock Holding History

PFM Health Sciences’s Portfolio SGEN Stock Details SGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-281,617
Closed -$59.7M – 80
2023
Q3 		$59.7M Buy
281,617
+25,318
+10% +$5.06M 2.81% 6
2023
Q2 		$49.3M Buy
256,299
+35,416
+16% +$7.04M 1.92% 18
2023
Q1 		$44.7M Buy
220,883
+28,499
+15% +$4.57M 1.98% 16
2022
Q4 		$24.7M Sell
192,384
-172,831
-47% -$22.3M 0.89% 46
2022
Q3 		$50M Buy
365,215
+82,820
+29% +$13.5M 1.81% 16
2022
Q2 		$50M Buy
+282,395
New +$40.7M 1.91% 16
2022
Q1 		– Sell
-268,527
Closed -$41.5M – 80
2021
Q4 		$41.5M Sell
268,527
-96,103
-26% -$16.1M 1.41% 35
2021
Q3 		$61.9M Sell
364,630
-118,355
-25% -$18.4M 1.82% 18
2021
Q2 		$76.3M Buy
+482,985
New +$71.8M 2.39% 11

Other funds holding SGEN

SCM
Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
FBC
Fairfield, Bush & Co Darien, Connecticut $203M AUM 38.37% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
SAG
Spotlight Asset Group Oakbrook Terrace, Illinois $143M AUM 20.66% 1-Year Est. Return

PFM Health Sciences's SGEN Position: Q4 2023 in Review

PFM Health Sciences sold out of Seagen Inc. Common Stock (SGEN) in Q4 2023, closing a stake of 281,617 shares — an estimated $59.7M sold.

PFM Health Sciences first reported a position in SGEN in Q2 2021 and held it in 9 quarters. The position peaked at $76.3M in Q2 2021. 6 funds tracked by Wall St. Rank hold SGEN as of Q4 2023.

  • PFM Health Sciences reported no remaining Seagen Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • PFM Health Sciences sold 281,617 Seagen Inc. Common Stock shares in Q4 2023, an estimated $59.7M.
  • PFM Health Sciences first reported a position in Seagen Inc. Common Stock in Q2 2021 and held it in 9 quarters.
  • PFM Health Sciences's Seagen Inc. Common Stock position peaked at $76.3M in Q2 2021.
  • 6 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q4 2023.

Based on PFM Health Sciences's 13F filing for Q4 2023, filed 14 Feb 2024.